Business Description
Tiziana Life Sciences Ltd
ISIN : BMG889121031
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 18.69 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -15.1 | |||||
3-Year EPS without NRI Growth Rate | -14.2 | |||||
3-Year FCF Growth Rate | -40.2 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.15 | |||||
9-Day RSI | 48.74 | |||||
14-Day RSI | 52.69 | |||||
6-1 Month Momentum % | -29.2 | |||||
12-1 Month Momentum % | -43.26 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.85 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 1.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.8 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -93.29 | |||||
ROA % | -74.04 | |||||
ROIC % | -443.41 | |||||
ROC (Joel Greenblatt) % | -7764.54 | |||||
ROCE % | -92.6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.89 | |||||
Price-to-Tangible-Book | 4.96 | |||||
EV-to-EBIT | -2.88 | |||||
EV-to-EBITDA | -2.89 | |||||
EV-to-FCF | -3.09 | |||||
Price-to-Net-Current-Asset-Value | 5.95 | |||||
Price-to-Net-Cash | 29.75 | |||||
Earnings Yield (Greenblatt) % | -34.72 | |||||
FCF Yield % | -30.66 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tiziana Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.17 | ||
Beta | -0.62 | ||
Volatility % | 68.54 | ||
14-Day RSI | 52.69 | ||
14-Day ATR (€) | 0.035625 | ||
20-Day SMA (€) | 0.6062 | ||
12-1 Month Momentum % | -43.26 | ||
52-Week Range (€) | 0.388 - 0.985 | ||
Shares Outstanding (Mil) | 100.31 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tiziana Life Sciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tiziana Life Sciences Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Tiziana Life Sciences Ltd Frequently Asked Questions
What is Tiziana Life Sciences Ltd(STU:0RP)'s stock price today?
When is next earnings date of Tiziana Life Sciences Ltd(STU:0RP)?
Does Tiziana Life Sciences Ltd(STU:0RP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |